Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Jan;166(1):169-78.
doi: 10.1111/j.1365-2133.2011.10586.x. Epub 2011 Dec 6.

Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial

UK Dermatology Clinical Trials Network’s PATCH Trial Team  1 ; Kim Thomas, Angela Crook, Katharine Foster, James Mason, Joanne Chalmers, John Bourke, Adam Ferguson, Nick Level, Andrew Nunn, Hywel Williams
Collaborators, Affiliations
Free PMC article
Randomized Controlled Trial

Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial

UK Dermatology Clinical Trials Network’s PATCH Trial Team et al. Br J Dermatol. 2012 Jan.
Free PMC article

Abstract

Background: Cellulitis (erysipelas) of the leg is a common, painful infection of the skin and underlying tissue. Repeat episodes are frequent, cause significant morbidity and result in high health service costs.

Objectives: To assess whether prophylactic antibiotics prescribed after an episode of cellulitis of the leg can prevent further episodes.

Methods: Double-blind, randomized controlled trial including patients recently treated for an episode of leg cellulitis. Recruitment took place in 20 hospitals. Randomization was by computer-generated code, and treatments allocated by post from a central pharmacy. Participants were enrolled for a maximum of 3 years and received their randomized treatment for the first 6 months of this period.

Results: Participants (n=123) were randomized (31% of target due to slow recruitment). The majority (79%) had suffered one episode of cellulitis on entry into the study. The primary outcome of time to recurrence of cellulitis included all randomized participants and was blinded to treatment allocation. The hazard ratio (HR) showed that treatment with penicillin reduced the risk of recurrence by 47% [HR 0·53, 95% confidence interval (CI) 0·26-1·07, P=0·08]. In the penicillin V group 12/60 (20%) had a repeat episode compared with 21/63 (33%) in the placebo group. This equates to a number needed to treat (NNT) of eight participants in order to prevent one repeat episode of cellulitis [95% CI NNT(harm) 48 to ∞ to NNT(benefit) 3]. We found no difference between the two groups in the number of participants with oedema, ulceration or related adverse events.

Conclusions: Although this trial was limited by slow recruitment, and the result failed to achieve statistical significance, it provides the best evidence available to date for the prevention of recurrence of this debilitating condition.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Participant flow diagram AE, adverse event; ITI, intent-to-treat.
Fig 2
Fig 2
Time to first recurrence of cellulitis.
See this image and copyright information in PMC

Comment in

References

    1. Cox NH, Colver GB, Paterson WD. Management and morbidity of cellulitis of the leg. J R Soc Med. 1998;91:634–7. - PMC - PubMed
    1. Carter K, Kilburn S, Featherstone P, et al. Cellulitis and treatment: a qualitative study of experiences. Br J Nurs. 2007;16:S22–4. - PubMed
    1. Levell N, Wingfield C, Garioch J. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011;164:1326–8. - PubMed
    1. Haan MN, Selby JV, Quesenberry CP, Jr, et al. The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971–1991. J Am Geriatr Soc. 1997;45:667–74. - PubMed
    1. Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006;20:834–9. - PubMed

Publication types

MeSH terms